An ACDF Multi-Center Study Using ViviGen Cellular Bone Matrix

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 1, 2016

Primary Completion Date

February 22, 2021

Study Completion Date

April 15, 2021

Conditions
Cervical SpondylosisDegenerative Intervertebral DiscsHerniated Disc
Interventions
OTHER

ViviGen

ViviGen Cellular Bone Matrix is a formulation of cryopreserved viable cortical cancellous bone matrix and demineralized bone. ViviGen is a Human Cells, Tissues, and Cellular and Tissue-based Product (HCT/P) as defined by the U.S. Food and Drug Administration in 21 CFR 127 1.3(d).

Sponsors

Lead Sponsor

All Listed Sponsors
lead

DePuy Spine

INDUSTRY

NCT02814825 - An ACDF Multi-Center Study Using ViviGen Cellular Bone Matrix | Biotech Hunter | Biotech Hunter